recombinant human vascular endothelial growth factor 165 (TargetMol)
Structured Review
Recombinant Human Vascular Endothelial Growth Factor 165, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmp/VEGF165+Protein%2C+Human%2C+Recombinant/pm42176839-49-24-32
Average 94 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity Article Snippet: Article Title: Design, synthesis, and neuroprotective evaluation of chiral butylphthalide-ligustrazine hybrids via the Keap1-Nrf2 pathway in ischemic stroke. Article Snippet: As a racemate, 3-n-butylphthalide (NBP) can be separated into its Sand R-enantiomers, with S-NBP reported to exhibit superior bioactivity.. To develop more potent anti-stroke agents with enhanced bioavailability, we therefore employed S-NBP as the lead compound.. Through structural modification and hybridization with ligustrazine (TMP), 20 novel S-NBP-TMP hybrids were designed and synthesized. Article Title: N -butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity Article Snippet: NBP and |

